Literature DB >> 10928083

Beware of contaminating mouse cells in human xenografts from nude mice.

J Yang1, A Liu, C Dougherty, X Chen, R Guzman, S Nandi.   

Abstract

Human tumor xenografts in nude mice are widely utilized model system for the transplantation of human surgical specimens and human established cell lines. Gene expression studies are often carried out in these model systems. With an increasing use of PCR based analyses, the extreme sensitivity of this technique poses a serious challenge with regards to the extent of contaminating host mouse cells in the human tumor xenografts. These xenografts are never free of host cell contamination. We detected mouse estrogen receptor expression in several human tumor xenografts using RT-PCR demonstrating that precaution is necessary when utilizing PCR based analyses in human tumor xenografts. A cytologically based methodology which distinguishes human versus mouse cells will be more suitable for ER expression studies using human xenograft models. Both (1) in situ hybridization using human probe and (2) immunocytochemistry using a monoclonal antibody directed against human cytokeratin have been used successfully to distinguish human cells versus host mouse cells in human xenografts in nude mice. Immunostaining of ER can then be utilized to determine the expression pattern of ER in the transplanted human cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928083

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

Authors:  Ferdinand Rombout; Leon Aarons; Mats Karlsson; Anthony Man; France Mentré; Peter Nygren; Amy Racine; Hans Schaefer; Jean-Louis Steimer; Iñaki Troconiz; Achiel van Peer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

Review 2.  Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-12-21       Impact factor: 3.285

3.  Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer.

Authors:  S C Presnell; E S Werdin; S Maygarden; J L Mohler; G J Smith
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 4.  Human benign prostatic hyperplasia heterotransplants as an experimental model.

Authors:  Lluis-A Lopez-Barcons
Journal:  Asian J Androl       Date:  2009-11-30       Impact factor: 3.285

5.  Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts.

Authors:  Sergio Y Alcoser; David J Kimmel; Suzanne D Borgel; John P Carter; Kelly M Dougherty; Melinda G Hollingshead
Journal:  BMC Biotechnol       Date:  2011-12-16       Impact factor: 2.563

6.  An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.

Authors:  Ningning Li; Roya Babaei-Jadidi; Federica Lorenzi; Bradley Spencer-Dene; Philip Clarke; Enric Domingo; Eugene Tulchinsky; Robert G J Vries; David Kerr; Yihang Pan; Yulong He; David O Bates; Ian Tomlinson; Hans Clevers; Abdolrahman S Nateri
Journal:  Oncogenesis       Date:  2019-02-19       Impact factor: 7.485

7.  Recombinant human acid sphingomyelinase as an adjuvant to sorafenib treatment of experimental liver cancer.

Authors:  Radoslav Savić; Xingxuan He; Isabel Fiel; Edward H Schuchman
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.